Welcome to IQ Proteomics. We specialize in quantitative multiplexed proteomic applications. We are a full service company providing proteomic characterization for a wide range of samples. We utilize technology leading instrumentation and methodologies, providing sensitive, accurate, and reproducible proteomic characterization.

Discovery Proteomics

Sensitive and accurate whole proteome characterization. Simultaneous analysis of up to eleven samples provides broad experimental design and robust statistics.

View details »

PTM Analysis

Quantify and characterize a broad range of post-translational modifications. Combine eleven samples to monitor time dependent signalling, dosage response or replicate measurements.

View details »

Targeted assays

High-throughput (custom) targeted assays enable accurate, sensitive and rapid screening of hundreds of targets eleven-times faster than traditional targeted approaches.

View details »


IQP exhibiting at WPW 2019

IQP will be exhibiting our technologies and services at World Pharma Week (June 17 - 20) in Boston, MA. We look forward to meeting you at our booth (338) or please contact IQP to schedule a meeting.

IQP awarded Phase II SBIR

IQP was recently awarded a Phase II SBIR, by the NIH, to continue efforts to develop our next-generation isobaric tag.

IQP goes global

IQ Proteomics has expanded the territory of their TMT™ license from Pierce Biotechnology, Inc. to include Canada and the countries of the European Union.